Literature DB >> 30482956

Anticancer therapy: Complementing tumour macrophage reprogramming.

M Teresa Villanueva.   

Abstract

Entities:  

Year:  2018        PMID： 30482956     DOI： 10.1038/nrd.2018.216

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.

Authors:  Terry R Medler; Dhaarini Murugan; Wesley Horton; Sushil Kumar; Tiziana Cotechini; Alexandra M Forsyth; Patrick Leyshock; Justin J Leitenberger; Molly Kulesz-Martin; Adam A Margolin; Zena Werb; Lisa M Coussens
Journal:  Cancer Cell       Date:  2018-10-08       Impact factor: 31.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.